results aftermath, page-14

Hi all. Had been hoping to post earlier! From a stats perspective it would take a bigger difference to achieve statistical significance at 95%. So this must be kept in mind when thinking about these results. I think worthind posted that quite a few would have been borderline - which I would agree with having worked with data for a long time.

What i like and what I was most interested in for phase III was continued safety n minimal side effects. This we have.

Yes the company needs a PR overhaul.

I still hold with quiet confidence. It is at worst the same as the best drug out there performance-wise but with superior secondaries... Not for the fainthearted though!!!

Good luck to all!